An important goal for the ME/CFS field is to find objective biomarkers for both symptom severity and diagnosis; TSPO as measured by PET radioligand binding is one such potential biomarker. Here, TSPO is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.